Essential function for the kinase TAK1 in innate and adaptive immune responses

Transforming growth factor-β–activated kinase 1 (TAK1) has been linked to interleukin 1 receptor and tumor necrosis factor receptor signaling. Here we generated mouse strains with conditional expression of a Map3k7 allele encoding part of TAK1. TAK1-deficient embryonic fibroblasts demonstrated loss of responses to interleukin 1β and tumor necrosis factor. Studies of mice with B cell–specific TAK1 deficiency showed that TAK1 was indispensable for cellular responses to Toll-like receptor ligands, CD40 and B cell receptor crosslinking. In addition, antigen-induced immune responses were considerably impaired in mice with B cell–specific TAK1 deficiency. TAK1-deficient cells failed to activate transcription factor NF-κB and mitogen-activated protein kinases in response to interleukin 1β, tumor necrosis factor and Toll-like receptor ligands. However, TAK1-deficient B cells were able to activate NF-κB but not the kinase Jnk in response to B cell receptor stimulation. These results collectively indicate that TAK1 is key in the cellular response to a variety of stimuli.

[1]  H. Green,et al.  QUANTITATIVE STUDIES OF THE GROWTH OF MOUSE EMBRYO CELLS IN CULTURE AND THEIR DEVELOPMENT INTO ESTABLISHED LINES , 1963, The Journal of cell biology.

[2]  J. Miyazaki,et al.  Efficient regulation of gene expression by adenovirus vector-mediated delivery of the CRE recombinase. , 1995, Biochemical and biophysical research communications.

[3]  K. Irie,et al.  Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction , 1995, Science.

[4]  David Baltimore,et al.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.

[5]  K. Irie,et al.  TAB1: An Activator of the TAK1 MAPKKK in TGF-β Signal Transduction , 1996, Science.

[6]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[7]  K. Rajewsky,et al.  B lymphocyte-specific, Cre-mediated mutagenesis in mice. , 1997, Nucleic acids research.

[8]  J. Ninomiya-Tsuji,et al.  The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway , 1999, Nature.

[9]  P Bailey,et al.  Double Edged Sword , 2002 .

[10]  D. Goeddel,et al.  Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice , 1999 .

[11]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.

[12]  Inder M. Verma,et al.  Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .

[13]  Zhijian J. Chen,et al.  Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.

[14]  T. Mak,et al.  Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. , 2000, Genes & development.

[15]  T. Muta,et al.  TAK1 mediates an activation signal from toll‐like receptor(s) to nuclear factor‐κB in lipopolysaccharide‐stimulated macrophages , 2000, FEBS letters.

[16]  K. Irie,et al.  TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. , 2000, Molecular cell.

[17]  S. Akira,et al.  Synergy and Cross-Tolerance Between Toll-Like Receptor (TLR) 2- and TLR4-Mediated Signaling Pathways1 , 2000, The Journal of Immunology.

[18]  Zhijian J. Chen,et al.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.

[19]  M. Karin,et al.  Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.

[20]  B. Lemaître,et al.  Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-kappaB-dependent innate immune responses. , 2001, Genes & development.

[21]  T. Mak,et al.  Bcl10 Is a Positive Regulator of Antigen Receptor–Induced Activation of NF-κ B and Neural Tube Closure , 2001, Cell.

[22]  M. Karin,et al.  Missing Pieces in the NF-κB Puzzle , 2002, Cell.

[23]  S. Akira,et al.  A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. , 2002, International immunology.

[24]  J. Ninomiya-Tsuji,et al.  Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis , 2002, Mechanisms of Development.

[25]  T. Kurosaki.  Regulation of B-cell signal transduction by adaptor proteins , 2002, Nature Reviews Immunology.

[26]  A. Brivanlou,et al.  Gene profiling during neural induction in Xenopus laevis: regulation of BMP signaling by post-transcriptional mechanisms and TAB3, a novel TAK1-binding protein , 2002, Development.

[27]  R. Gaynor,et al.  Role of the TAB2‐related protein TAB3 in IL‐1 and TNF signaling , 2003, The EMBO journal.

[28]  V. Dixit,et al.  Mice Lacking the CARD of CARMA1 Exhibit Defective B Lymphocyte Development and Impaired Proliferation of Their B and T Lymphocytes , 2003, Current Biology.

[29]  R. Surabhi,et al.  TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB Pathway , 2003 .

[30]  D. Littman,et al.  Requirement for CARMA1 in Antigen Receptor-Induced NF-κB Activation and Lymphocyte Proliferation , 2003, Current Biology.

[31]  Chris Bakal,et al.  The MAGUK family protein CARD11 is essential for lymphocyte activation. , 2003, Immunity.

[32]  V. Dixit,et al.  Regulation of NF-κB-Dependent Lymphocyte Activation and Development by Paracaspase , 2003, Science.

[33]  B. Aggarwal.  Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.

[34]  S. Akira,et al.  Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.

[35]  B. Devlin,et al.  Role of different B-cell subsets in the specific and polyclonal immune response to T-independent antigens type 2. , 2003, Immunology letters.

[36]  Jürgen Ruland,et al.  Differential requirement for Malt1 in T and B cell antigen receptor signaling. , 2003, Immunity.

[37]  S. Akira,et al.  TAB2 Is Essential for Prevention of Apoptosis in Fetal Liver but Not for Interleukin-1 Signaling , 2003, Molecular and Cellular Biology.

[38]  S. Morris,et al.  Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells , 2003, Nature Immunology.

[39]  T. Giese,et al.  IL-12p70-Dependent Th1 Induction by Human B Cells Requires Combined Activation with CD40 Ligand and CpG DNA 1 , 2004, The Journal of Immunology.

[40]  P. Cohen,et al.  TAB3, a new binding partner of the protein kinase TAK1. , 2004, The Biochemical journal.

[41]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[42]  Zhengfan Jiang,et al.  Identification of a human NF-κB-activating protein, TAB3 , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Zhijian J. Chen,et al.  The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. , 2004, Molecular cell.

[44]  Zhijian J. Chen,et al.  TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. , 2004, Molecular cell.

[45]  M. Thome.  CARMA1, BCL-10 and MALT1 in lymphocyte development and activation , 2004, Nature Reviews Immunology.

[46]  S. Akira,et al.  Elucidation of the c-Jun N-Terminal Kinase Pathway Mediated by Epstein-Barr Virus-Encoded Latent Membrane Protein 1 , 2004, Molecular and Cellular Biology.

[47]  Honglin Zhou,et al.  Bcl10 activates the NF-κB pathway through ubiquitination of NEMO , 2004, Nature.

[48]  Kunihiro Matsumoto,et al.  Role of the TAK1-NLK-STAT3 pathway in TGF-β-mediated mesoderm induction , 2004 .